Search research articles
Contact Us
Filters
Showing results (51-60 of 66) with videos related to
Page
of 7
Sort By:
Nature Cancer
|
March 13, 2024
Author Correction: Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis
Yuliana Astuti, Meirion Raymant, Valeria Quaranta, et al.
Archives of Toxicology
|
April 4, 2016
Mechanistic evaluation of primary human hepatocyte culture using global proteomic analysis reveals a selective dedifferentiation profile
James A Heslop, Cliff Rowe, Joanne Walsh, et al.
Nature Cancer
|
February 14, 2024
Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis
Yuliana Astuti, Meirion Raymant, Valeria Quaranta, et al.
Digestive Surgery
|
April 16, 2025
Current Practice in the Treatment of Colorectal Liver Metastases by Irreversible Electroporation: An International Questionnaire Survey (LIVERMET-IRE-Q)
Harry V M Spiers, Saurabh Jamdar, Santhalingam Jegatheeswaran, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
July 11, 2015
Comparative Proteomic Characterization of 4 Human Liver-Derived Single Cell Culture Models Reveals Significant Variation in the Capacity for Drug Disposition, Bioactivation, and Detoxication
Rowena L C Sison-Young, Dimitra Mitsa, Rosalind E Jenkins, et al.
BJS Open
|
May 22, 2022
The dilemma of the disappeared colorectal liver metastasis: systematic review of reviews and evidence gap map
Ahmed Nassar, Sorin Cimpean, Amir Abdelhamid, et al.
The British Journal of Surgery
|
September 28, 2022
SARS-CoV-2 in the abdomen or pelvis: SAFE SURGERY study
Dale Vimalachandran, Robert P Jones, Ed Dickson, et al.
Cancers
|
July 14, 2023
Impact of COVID-19 on 1-Year Survival Outcomes in Hepatocellular Carcinoma: A Multicenter Cohort Study
Shuell De Souza, Jeffrey Kahol de Jong, Ylenia Perone, et al.
Oncotarget
|
June 23, 2018
The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancer
Jonathan P Evans, Boleslaw K Winiarski, Paul A Sutton, et al.
Oncotarget
|
February 19, 2019
Correction: The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancer
Jonathan P Evans, Boleslaw K Winiarski, Paul A Sutton, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 66) with videos related to
Sort By:
Page
of 7
Nature Cancer
|
March 13, 2024
Author Correction: Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis
Yuliana Astuti, Meirion Raymant, Valeria Quaranta, et al.
Archives of Toxicology
|
April 4, 2016
Mechanistic evaluation of primary human hepatocyte culture using global proteomic analysis reveals a selective dedifferentiation profile
James A Heslop, Cliff Rowe, Joanne Walsh, et al.
Nature Cancer
|
February 14, 2024
Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis
Yuliana Astuti, Meirion Raymant, Valeria Quaranta, et al.
Digestive Surgery
|
April 16, 2025
Current Practice in the Treatment of Colorectal Liver Metastases by Irreversible Electroporation: An International Questionnaire Survey (LIVERMET-IRE-Q)
Harry V M Spiers, Saurabh Jamdar, Santhalingam Jegatheeswaran, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
July 11, 2015
Comparative Proteomic Characterization of 4 Human Liver-Derived Single Cell Culture Models Reveals Significant Variation in the Capacity for Drug Disposition, Bioactivation, and Detoxication
Rowena L C Sison-Young, Dimitra Mitsa, Rosalind E Jenkins, et al.
BJS Open
|
May 22, 2022
The dilemma of the disappeared colorectal liver metastasis: systematic review of reviews and evidence gap map
Ahmed Nassar, Sorin Cimpean, Amir Abdelhamid, et al.
The British Journal of Surgery
|
September 28, 2022
SARS-CoV-2 in the abdomen or pelvis: SAFE SURGERY study
Dale Vimalachandran, Robert P Jones, Ed Dickson, et al.
Cancers
|
July 14, 2023
Impact of COVID-19 on 1-Year Survival Outcomes in Hepatocellular Carcinoma: A Multicenter Cohort Study
Shuell De Souza, Jeffrey Kahol de Jong, Ylenia Perone, et al.
Oncotarget
|
June 23, 2018
The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancer
Jonathan P Evans, Boleslaw K Winiarski, Paul A Sutton, et al.
Oncotarget
|
February 19, 2019
Correction: The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancer
Jonathan P Evans, Boleslaw K Winiarski, Paul A Sutton, et al.
Page
of 7